- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Afya Ltd (AFYA)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/29/2025: AFYA (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $18.15
1 Year Target Price $18.15
| 1 | Strong Buy |
| 2 | Buy |
| 2 | Hold |
| 1 | Sell |
| 3 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -47.45% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.36B USD | Price to earnings Ratio 10.31 | 1Y Target Price 18.15 |
Price to earnings Ratio 10.31 | 1Y Target Price 18.15 | ||
Volume (30-day avg) 9 | Beta 0.52 | 52 Weeks Range 13.47 - 19.90 | Updated Date 12/28/2025 |
52 Weeks Range 13.47 - 19.90 | Updated Date 12/28/2025 | ||
Dividends yield (FY) 1.55% | Basic EPS (TTM) 1.45 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 20.08% | Operating Margin (TTM) 29.88% |
Management Effectiveness
Return on Assets (TTM) 8.35% | Return on Equity (TTM) 16.72% |
Valuation
Trailing PE 10.31 | Forward PE 7.78 | Enterprise Value 1714120822 | Price to Sales(TTM) 0.37 |
Enterprise Value 1714120822 | Price to Sales(TTM) 0.37 | ||
Enterprise Value to Revenue 2.6 | Enterprise Value to EBITDA 5.79 | Shares Outstanding 46894952 | Shares Floating 7894329 |
Shares Outstanding 46894952 | Shares Floating 7894329 | ||
Percent Insiders 68.11 | Percent Institutions 19.82 |
Upturn AI SWOT
Afya Ltd

Company Overview
History and Background
Afya Ltd. (Nasdaq: AFYA) was founded in 2015 and is a leading provider of integrated higher education medical and health sciences platform in Brazil. It has grown significantly through both organic expansion and strategic acquisitions, establishing itself as a dominant player in the Brazilian educational market. Key milestones include its IPO on Nasdaq in 2019, which provided capital for further expansion and technological advancements. The company has consistently focused on expanding its course offerings and geographical reach within Brazil.
Core Business Areas
- Postgraduate Courses: Afya offers a comprehensive range of specialized postgraduate courses for medical and health professionals, focusing on continuous professional development and career advancement. This segment is a cornerstone of their business, catering to a large and growing demand for specialized medical education in Brazil.
- Medical School Entrance Exams and Preparatory Courses: Afya provides preparatory courses and materials for students aspiring to enter medical and other health science programs. This segment leverages their brand recognition and expertise in the medical education field to attract students early in their academic journey.
- Undergraduate Medical and Health Sciences Education: Through its network of accredited medical and health sciences schools, Afya offers undergraduate degrees in medicine and other health-related fields. This segment represents a significant portion of their revenue and student base.
- Digital Solutions and Content: Afya develops and offers digital platforms and content for educational purposes, including online learning tools, simulations, and digital textbooks. This segment is crucial for modernizing their offerings and reaching a wider audience.
Leadership and Structure
Afya Ltd. is led by a seasoned management team with extensive experience in the education and healthcare sectors. The company is structured to efficiently manage its diverse educational offerings across multiple campuses and digital platforms. Key leadership roles typically include a CEO, CFO, and heads of various business segments and operational divisions. The organizational structure is designed to facilitate integration of acquired entities and maintain high standards of academic quality and operational efficiency.
Top Products and Market Share
Key Offerings
- Undergraduate Medical Degrees: Afya's undergraduate medical programs are highly sought after and represent a significant revenue driver. The company operates several accredited medical schools, offering a robust curriculum aligned with Brazilian medical standards. Competitors include other large private university groups and public medical schools in Brazil. Market share data for specific degree programs is not publicly detailed, but Afya is a dominant player in private medical education in Brazil.
- Postgraduate Medical Specializations: Afya offers a wide array of specialized postgraduate courses for doctors seeking to deepen their knowledge and skills in specific medical fields. These courses are critical for career advancement in the competitive Brazilian healthcare market. Competitors include other medical education institutions and professional medical societies. Afya holds a significant market share in this segment due to its extensive network and reputation.
- Medical Entrance Exam Preparation (Medicina Preparatu00f3rio): This product line targets students preparing for the highly competitive entrance exams to medical schools in Brazil. Afya utilizes its expertise and brand recognition to attract a large student base. Competitors include numerous smaller preparatory course providers. This is a key customer acquisition channel for Afya.
- Digital Health Learning Platforms: Afya provides digital solutions that enhance learning for both undergraduate and postgraduate students, including access to digital libraries, simulation tools, and online course modules. These platforms aim to offer a blended learning experience. Competitors include general ed-tech companies and other medical education providers with digital offerings.
Market Dynamics
Industry Overview
The higher education industry in Brazil, particularly in the medical and health sciences, is characterized by high demand, stringent regulatory oversight, and a growing need for skilled healthcare professionals. The market is also seeing an increasing adoption of digital learning solutions and a consolidation trend among educational providers. Economic factors and government policies significantly influence student enrollment and tuition fees.
Positioning
Afya is positioned as a leading integrated player in the Brazilian higher education medical and health sciences market. Its competitive advantages include its extensive network of accredited institutions, strong brand recognition, a comprehensive curriculum, and a growing digital presence. The company benefits from economies of scale and the ability to cross-sell its diverse educational offerings.
Total Addressable Market (TAM)
The total addressable market for higher education in Brazil, especially in the medical and health sciences, is substantial. While specific TAM figures for Afya's niche are dynamic, it represents billions of dollars annually in tuition and related fees. Afya is well-positioned to capture a significant share of this TAM, particularly within the private sector, by leveraging its scale, diversified offerings, and strategic acquisitions.
Upturn SWOT Analysis
Strengths
- Strong brand recognition and reputation in Brazil's medical education sector.
- Extensive network of accredited educational institutions across Brazil.
- Diversified revenue streams from undergraduate, postgraduate, and preparatory courses.
- Significant investment in digital learning technologies and platforms.
- Proven track record of successful strategic acquisitions to expand market share and offerings.
Weaknesses
- Dependence on the Brazilian regulatory environment for education and healthcare.
- Potential integration challenges with newly acquired entities.
- Sensitivity to economic downturns that may affect student affordability.
- Intense competition from both public and private educational institutions.
Opportunities
- Expansion into new health science specializations and related fields.
- Further development and monetization of digital learning platforms and content.
- Potential for international expansion or partnerships, though currently focused on Brazil.
- Leveraging AI and data analytics to personalize learning and improve student outcomes.
- Increased demand for healthcare professionals in Brazil.
Threats
- Changes in government regulations or educational policies.
- Economic instability in Brazil impacting student enrollment and disposable income.
- Intensifying competition leading to price wars or market saturation.
- Technological disruptions requiring continuous adaptation and investment.
- Reputational damage from accreditation issues or academic controversies.
Competitors and Market Share
Key Competitors
- u00c2nima Educau00e7u00e3o S.A. (B3: ANIM3)
- Cogna Educau00e7u00e3o S.A. (B3: COGN3)
- Ser Educacional S.A. (B3: SEER3)
Competitive Landscape
Afya possesses a strong advantage due to its focused strategy on medical and health sciences education, which has a high barrier to entry and consistent demand. Its integrated platform, combining physical campuses with digital tools, offers a comprehensive student experience. However, it faces competition from larger, diversified educational groups and specialized medical schools that may have established local dominance or specific niche expertise.
Major Acquisitions
UNISEB - Centro Universitu00e1rio
- Year: 2021
- Acquisition Price (USD millions): 100
- Strategic Rationale: Acquisition of UNISEB expanded Afya's undergraduate offerings and geographical presence in key regions of Brazil, strengthening its position in higher education.
Medcel
- Year: 2020
- Acquisition Price (USD millions): 110
- Strategic Rationale: Integration of Medcel, a leading provider of medical residency preparation content and services, further solidified Afya's leadership in postgraduate medical education and exam preparation.
Famec - Faculdade de Medicina de Catanduva
- Year: 2022
- Acquisition Price (USD millions): 80
- Strategic Rationale: Acquisition of Famec provided Afya with an additional medical school, increasing its capacity for undergraduate medical education and its reach within a new territory.
Growth Trajectory and Initiatives
Historical Growth: Afya has experienced substantial historical growth, driven by a strategic M&A approach that integrates well-regarded educational institutions into its platform. Organic growth has also been a contributing factor, through increased student enrollment, expansion of course offerings, and leveraging its digital capabilities. The company has successfully scaled its operations across Brazil.
Future Projections: Analyst estimates for Afya's future growth typically project continued revenue expansion, driven by further market penetration, potential new course offerings, and ongoing digital transformation. Profitability is expected to grow in line with revenue, with potential margin improvements as economies of scale are realized. Future acquisitions remain a key component of their growth strategy.
Recent Initiatives: Recent initiatives likely include the integration of recently acquired educational institutions, expansion of their digital learning ecosystem, development of new specialized courses to meet market demands, and investments in faculty development and educational technology to enhance student experience and outcomes.
Summary
Afya Ltd. is a strong and well-positioned leader in Brazil's medical and health sciences education market. Its integrated platform, strategic acquisitions, and focus on digital learning have driven consistent growth and profitability. The company benefits from high demand for healthcare professionals and a robust student base. Key areas to watch include regulatory changes in the education sector and the continued successful integration of its growing portfolio of institutions. Overall, Afya demonstrates a solid growth trajectory and a commitment to academic excellence.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Afya Ltd. Investor Relations
- SEC Filings (Form 20-F)
- Reputable financial news outlets
- Industry analysis reports
Disclaimers:
This information is for analytical purposes only and should not be considered investment advice. Financial data and market share estimates are subject to change and may be based on publicly available information which may not be exhaustive. Specific financial figures for 'Financial Metrics' and 'Year-over-Year Analysis' would require real-time access to financial statements.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Afya Ltd
Exchange NASDAQ | Headquaters Nova Lima, MG, Brazil | ||
IPO Launch date 2019-07-19 | CEO - | ||
Sector Consumer Defensive | Industry Education & Training Services | Full time employees - | Website https://www.afya.com.br |
Full time employees - | Website https://www.afya.com.br | ||
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. In addition, it offers printed and digital content, as well as an online medical education platform and practical medical training services. Further, the company offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics, and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. Afya Limited was founded in 1999 and is headquartered in Nova Lima, Brazil.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

